Abstract
Nearly half the US population will meet criteria for a neuropsychiatric disorder at some point in their lives, and 1 in 17 has a seriously debilitating illness. Although not all affected adults had an identified disorder as a child, increasingly these psychopathologies are conceptualized as the late-stage culmination of aberrant developmental processes shaped by a complex interplay of genes and experience, including experiences in utero. Decades of studies with pregnant animals demonstrate that stress-elicited perturbations in maternal biology affect offspring neurodevelopment. Studies of stress in pregnant women largely mirror these findings. Pregnant women with anxiety and/or depression experience greater life stress, and illness-related alterations in their neurobiology, with a potential to impact fetal neurobehavioral development via associated changes in the intrauterine environment and/or pharmacologic interventions. This article critically reviews findings on child development (including fetal neurobehavior) related to maternal depression, anxiety, and pharmacological treatments, primarily selective serotonin reuptake inhibitors (SSRIs). The hypothesis under review is that, in addition to genetics and characteristics of the postnatal environment, the familial transmission of risk for neuropsychiatric disorders involves a “third path”—prenatal exposure to psychiatric illness and its treatment.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- CRH:
-
corticotrophin-releasing hormone
- HR:
-
heart rate
- SSRI:
-
selective serotonin reuptake inhibitor
- UBF:
-
uterine blood flow
REFERENCES
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE 2005 Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593–602
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS 2003 The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095–3105
Marcus SM 2009 Depression during pregnancy: rates, risks and consequences—motherisk update 2008. Can J Clin Pharmacol 16: e15–e22
Heron J, O'Connor TG, Evans J, Golding J, Glover V 2004 The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 80: 65–73
Bakker MK, Kolling P, van den Berg PB, de Walle HE, de Jong van den Berg LT 2008 Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 65: 600–606
Alwan S, Reefhuis J, Rasmussen SA, Friedman JM 2010 National Birth Defects Prevention Study Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol 51: 264–270
Cooper WO, Willy ME, Pont SJ, Ray WA 2007 Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 196: 544.e1–544.e5
Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES, Nestler EJ 2010 Early life programming and neurodevelopmental disorders. Biol Psychiatry 68: 314–319
Fonagy P, Target M 1997 Attachment and relective function: their role in self-organiztion. Dev Psychopathol 9: 679–700
Weissman MM, Warner V, Wickramaratne P, Moreau D, Olfson M 1997 Offspring of depressed parents. Arch Gen Psychiatry 54: 932–940
Owen D, Andrews MH, Matthews SG 2005 Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Biobehav Rev 29: 209–226
Talge NM, Neal C, Glover V 2007 Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry 48: 245–261
DiPietro JA, Novak MF, Costigan KA, Atella LD, Reusing SP 2006 Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev 77: 573–587
O'Connor TG, Heron J, Golding J, Beveridge M, Glover V 2002 Maternal antenatal anxiety and children's behavioral/emotional problems at 4 years: report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry 180: 502–508
Pawlby S, Hay DF, Sharp D, Waters CS, O'Keane V 2009 Antenatal depression predicts depression in adolescent offspring: prospective longitudinal community-based study. J Affect Disord 113: 236–243
O'Connor TG, Heron J, Glover V 2002 The ALSPAC Study Team Antenatal anxiety predicts child behavior/emotional problems independently of postnatal depression. J Am Acad Child Adolesc Psychiatry 41: 1470–1477
O'Connor TG, Heron J, Golding J, Glover V 2003 Maternal antenatal anxiety and behavioural/emotional problems in children: a test of a programming hypothesis. J Child Psychol Psychiatry 44: 1025–1036
O'Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V 2005 Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 58: 211–217
Van den Bergh BR, Marcoen A 2004 High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems and anxiety in 8–9 year olds. Child Dev 75: 1085–1097
Van den Bergh BR, Mennes M, Oosterlaan J, Stevens V, Stiers P, Marcoen A, Lagae L 2005 High antenatal maternal anxiety is related to impulsivity during performance on cognitive tasks in 14- and 15-year-olds. Neurosci Biobehav Rev 29: 259–269
Van den Bergh BR, Mennes M, Stevens V, van der Meere J, Borger N, Stiers P, Marcoen A, Lagae L 2006 ADHD deficit as measured in adolescent boys with a continuous performance task is related to antenatal maternal anxiety. Pediatr Res 59: 78–82
Van den Bergh BR, Van Calster B, Smits T, Van Huffel S, Lagae L 2008 Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 33: 536–545
Buss C, Davis EP, Muftuler LT, Head K, Sandman CA 2010 High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6–9-year-old children. Psychoneuroendocrinology 35: 141–153
Pruessner JC, Dedovic K, Khalili-Mahani N, Engert V, Pruessner M, Buss C, Renwick R, Dagher A, Meaney MJ, Lupien S 2008 Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol Psychiatry 63: 234–240
Evans GW, Gonnella C, Marcynyszyn LA, Gentile L, Salpekar N 2005 The role of chaos in poverty and children's socioemotional adjustment. Psychol Sci 16: 560–565
Abrams SM, Field T, Scafidi F, Prodromidis M 1995 Newborns of depressed mothers. Infant Ment Health J 16: 233–239
Field T, Diego M, Dieter J, Hernandez-Reif M, Schanberg S, Kuhn C, Yando R, Bendell D 2004 Prenatal depression effects on the fetus and the newborn. Infant Behav Dev 27: 216–229
Brouwers AP, van Baar AL, Pop VJ 2001 Maternal anxiety during pregnancy and subsequent infant development. Infant Behav Dev 24: 95–106
Davis PE, Snidman N, Wadhwa P, Glynn LM, Schetter CD, Sandman CA 2004 Prenatal maternal anxiety and depression predict negative behavioral reactivity in infancy. Infancy 6: 319–331
Werner EA, Myers MM, Fifer WP, Cheng B, Fang Y, Allen R, Monk C 2007 Prenatal predictors of infant temperament. Dev Psychobiol 49: 474–484
Brennan PA, Le Brocque R, Hammen C 2003 Maternal depression, parent-child relationships, and resilient outcomes in adolescence. J Am Acad Child Adolesc Psychiatry 42: 1469–1477
Brand SR, Engel SM, Canfield RL, Yehuda R 2006 The effect of maternal PTSD following in utero trauma exposure on behavior and temperament in the 9-month-old infant. Ann N Y Acad Sci 1071: 454–458
Warren SL, Gunnar MR, Kagan J, Anders TF, Simmens SJ, Rones M, Wease S, Aron E, Dahl RE, Sroufe LA 2003 Maternal panic disorder: infant temperament, neurophysiology, and parenting behaviors. J Am Acad Child Adolesc Psychiatry 42: 814–825
Kaplan LA, Evans L, Monk C 2008 Effects of mothers' prenatal psychiatric status and postnatal caregiving on infant biobehavioral regulation: can prenatal programming be modified?. Early Hum Dev 84: 249–256
Grant KA, McMahon C, Austin MP, Reilly N, Leader L, Ali S 2009 Maternal prenatal anxiety, postnatal caregiving and infants' cortisol responses to the still-face procedure. Dev Psychobiol 51: 625–637
Field T, Diego M, Hernandez-Reif M, Vera Y, Gil K, Schanberg S, Kuhn C, Gonzalez-Garcia A 2004 Prenatal maternal biochemistry predicts neonatal biochemistry. Int J Neurosci 114: 933–945
McEwen BS, Gianaros PJ 2010 Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci 1186: 190–222
Monk C, Myers MM, Sloan RP, Werner L, Jeon J, Tager F, Fifer WP 2004 Fetal heart rate reactivity differs by women's psychiatric status: an early marker for developmental risk?. J Am Acad Child Adolesc Psychiatry 43: 283–290
Monk C, Fifer WP, Myers MM, Bagiella E, Duong JK, Chen IS, Leotti L, Altincatal A 2010 Effects of maternal breathing rate, psychiatric status, and cortisol on fetal heart rate. Dev Psychobiol, [epub ahead of print]
Allister L, Lester BM, Carr S, Liu E 2001 The effects of maternal depression on fetal heart rate responce to vibroacoustic stimulation. Dev Neuropsychol 20: 639–651
DiPietro JA, Caulfield L, Costigan KA, Merialdi M, Nguyen RH, Zavaleta N, Gurewitsch ED 2004 Fetal neurobehavioral development: a tale of two cities. Dev Psychol 40: 445–456
Dieter J, Emory E, Johnson K, Raynor B 2008 Maternal depression and anxiety effects on the human fetus: preliminary findings and clinical implications. Infant Ment Health J 29: 420–441
DiPietro JA, Ghera MM, Costigan KA 2008 Prenatal origins of temperamental reactivity in early infancy. Early Hum Dev 84: 569–575
Weinstock M 2005 The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav Immun 19: 296–308
Rice F, Harold GT, Boivin J, van den Bree M, Hay DF, Thapar A 2010 The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences. Psychol Med 40: 335–345
Golombok S, Lycett E, MacCallum F, Jadva V, Murray C, Rust J, Abdalla H, Jenkins J, Margara R 2004 Parenting infants conceived by gamete donation. J Fam Psychol 18: 443–452
Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL 2005 Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293: 2372–2383
Galbally M, Lewis AJ, Lum J, Buist A 2009 Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study. Aust N Z J Psychiatry 43: 846–854
Ferreira E, Carceller AM, Agogué C, Martin BZ, St-André M, Francoeur D, Bérard A 2007 Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 119: 52–59
Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G 2006 Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 160: 173–176
Warburton W, Hertzman C, Oberlander TF 2010 A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand 121: 471–479
Zeskind PS, Stephens LE 2004 Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113: 368–375
Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W 2005 Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 115: 411–425
Oberlander TF, Grunau R, Mayes L, Riggs W, Rurak D, Papsdorf M, Misri S, Weinberg J 2008 Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum Dev 84: 689–697
Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G 2002 Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 159: 1889–1895
Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE 2003 Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 142: 402–408
Pedersen LH, Henricksen TB, Olsen J 2010 Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 125: e600–e608
Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE, Oberlander TF 2006 Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry 163: 1026–1032
Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE 2007 Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med 161: 22–29
Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Gruneau RE 2010 Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med 164: 444–451
Ansorge MS, Morelli E, Gingrich JA 2008 Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28: 199–207
Maciag D, Coppinger D, Paul IA 2006 Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development. Brain Res 1125: 171–175
Wadhwa PD, Glynn L, Hobel CJ, Garite TJ, Porto M, Chicz-DeMet A, Wigelsworth AK, Sandman CA 2002 Behavioral perinatology: biobehavioral processes in human fetal development. Regul Pept 108: 149–157
Sarkar P, Bergman K, O'Connor TG, Glover V 2008 Maternal antenatal anxiety and amniotic fluid cortisol and testosterone: possible implications for foetal programming. J Neuroendocrinol 20: 489–496
Teixeira J, Martin D, Prendiville O, Glover V 2005 The effects of acute relaxation on indices of anxiety during pregnancy. J Psychosom Obstet Gynaecol 26: 271–276
Mairesse J, Lesage J, Breton C, Breant B, Hahn T, Darnaudery M, Dickson SL, Seckl J, Blondeau B, Vieau D, Maccari S, Viltart O 2007 Maternal stress alters endocrine function of the feto-placental unit in rats. Am J Physiol Endocrinol Metab 292: E1526–E1533
Petraglia F, Florio P, Nappi C, Genazzani AR 1996 Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev 17: 156–186
Gitau R, Cameron A, Fisk NM, Glover V 1998 Fetal exposure to maternal cortisol. Lancet 352: 707–708
Sarkar P, Bergman K, Fisk NM, O'Connor TG, Glover V 2007 Ontogeny of foetal exposure to maternal cortisol using midtrimester amniotic fluid as a biomarker. Clin Endocrinol (Oxf) 66: 636–640
Gitau R 2001 Umbilical cord cortisol levels as an incidacator of the fetal stress response to assisted vaginal delivery. Eur J Obstet Gynecol Reprod Biol 98: 14–17
Sandman CA, Wadhwa P, Glynn L, Chicz-Demet A, Porto M, Garite TJ 1999 Corticotrophin-releasing hormone and fetal responses in human pregnancy. Ann N Y Acad Sci 897: 66–75
Fink NS, Urech C, Berger CT, Hoesli I, Holzgreve W, Bitzer J, Alder J 2010 Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers. J Matern Fetal Neonatal Med 23: 488–500
DiPietro JA, Kivlighan KT, Costigan KA, Laudenslager ML 2009 Fetal motor activity and maternal cortisol. Dev Psychobiol 51: 505–512
de Weerth C, van Hees Y, Buitelaar JK 2003 Prenatal maternal cortisol levels and infant behavior during the first 5 months. Early Hum Dev 74: 139–151
Davis EP, Townsend EL, Gunnar MR, Guiang SF, Lussky RC, Cifuentes RF, Georgieff MK 2006 Antenatal betamethasone treatment has a persisting influence on infant HPA axis regulation. J Perinatol 26: 147–153
Davis EP, Sandman CA 2010 The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Dev 81: 131–148
Davis EP, Glynn LM, Schetter CD, Hobel C, Chicz-Demet A, Sandman CA 2007 Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry 46: 737–746
Bergman K, Glover V, Sarkar P, Abbott DH, O'Connor TG 2010 In utero cortisol and testosterone exposure and fear reactivity in infancy. Horm Behav 57: 306–312
Morrison JL, Riggs KW, Chien C, Gruber N, McMillen IC, Rurak DW 2004 Chronic maternal fluoxetine infusion in pregnant sheep: effects on the maternal and fetal hypothalamic-pituitary-adrenal axes. Pediatr Res 56: 40–46
Cottrell EC, Seckl JR 2009 Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 3: 19
Sjöström K, Valentin L, Thelin T, Marsal K 1997 Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol 74: 149–155
Teixeira JM, Fisk NM, Glover V 1999 Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ 318: 153–157
Sciscione AC, Hayes EJ 2009 Uterine artery Doppler flow studies in obstetric practice. Am J Obstet Gynecol 201: 121–126
Kent A, Hughes P, Ormerod L, Jones G, Thilaganathan B 2002 Uterine artery resistance and anxiety in the second trimester of pregnancy. Ultrasound Obstet Gynecol 19: 177–179
Maina G, Saracco P, Giolito MR, Danelon D, Bogetto F, Todros T 2008 Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J Affect Disord 111: 214–220
Harville EW, Savitz DA, Dole N, Herring AH, Thorp JM, Light KC 2008 Stress and placental resistance measured by Doppler ultrasound in early and mid-pregnancy. Ultrasound Obstet Gynecol 32: 23–30
Vythilingum B, Geerts L, Fincham D, Roos A, Faure S, Jonkers J, Stein DJ 2010 Association between antenatal distress and uterine artery pulsatility index. Arch Womens Ment Health 13: 359–364
Morrison JL, Chien C, Riggs KW, Gruber N, Rurak D 2002 Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth. Pediatr Res 51: 433–442
Ansorge MS, Hen R, Gingrich JA 2007 Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol 7: 8–17
Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA 2004 Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879–881
Homberg JR, Schubert D, Gaspar P 2010 New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci 31: 60–65
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Monk, C., Fitelson, E. & Werner, E. Mood Disorders And Their Pharmacological Treatment During Pregnancy: Is the Future Child Affected?. Pediatr Res 69, 3–10 (2011). https://doi.org/10.1203/PDR.0b013e3182131a2e
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e3182131a2e
This article is cited by
-
Intergenerational transmission of depression: clinical observations and molecular mechanisms
Molecular Psychiatry (2019)
-
CD4+ but not CD8+ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice
Translational Psychiatry (2013)
